Multiple Adverse Outcomes Associated with Risperidone in People with Dementia: An Individual Participant Data Meta-Analysis
Most adverse effects occur after 4 weeks of treatment. Attention to baseline risk factors is essential to minimise harm. Risk-benefit calculators may guide individualised prescribing.
Authors
- Sarah Nicole Hilmer (ORCID: https://orcid.org/0000-0002-5970-1501)
- Christine Y. Lu (ORCID: https://orcid.org/0000-0002-7550-6837)
- Lee-Fay Low
- Edwin C. K. Tan
- Tuan A. Nguyen
- Yun-Hee Jeon
- Edward C. Y. Lau
- Hieu Hoc Le
Institutions
- The University of Sydney (AU)
- Trinity College Dublin (IE)
- Royal North Shore Hospital (AU)
- National Ageing Research Institute (AU)
- Northern Sydney Local Health District (AU)
- Swinburne University of Technology (AU)
Publication Details
- Journal
- CNS Drugs
- Published
- 2026-03-03
- DOI
- https://doi.org/10.1007/s40263-026-01282-z
- Citations
- 1
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 33.12
Funders
- Yale University
- Dementia Australia